| Literature DB >> 27130156 |
Sukhraj Pal S Dhami1, Shanthi S Kappala1, Alexander Thompson2, Eva Szegezdi3.
Abstract
Acute myeloid leukaemia (AML) is a hierarchically structured malignancy in which aberrant leukemic stem cells drive the production of leukaemic blast cell clones. AML cells strictly depend on the bone marrow microenvironment (BMM) in which they reside. Classical AML cell cultures fail to mimic the BMM and, therefore, drug discovery studies are dominated by in vivo models. However, animal models are time consuming, labour intensive, provide limited mechanistic insight, and are unsuited for high-throughput studies, necessitating the development of novel AML models. The evolving ex vivo BMM-mimicking culture systems aim to fill this gap, with increasing success. Here, we discuss how AML-microenvironment co-culture models advance our understanding of this disease, and highlight their future potential for translational AML research.Entities:
Mesh:
Year: 2016 PMID: 27130156 DOI: 10.1016/j.drudis.2016.04.019
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851